Document:

Exhibit
10.33

 

 

Warrant
Certificate No.______

 

NEITHER
THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES ISSUABLE UPON THE EXERCISE OF THIS WARRANT HAVE BEEN REGISTERED UNDER
THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR ANY STATE SECURITIES LAWS, AND NEITHER SUCH SECURITIES NOR ANY INTEREST
THEREIN MAY BE OFFERED, SOLD, ASSIGNED OR OTHERWISE TRANSFERRED UNLESS (1) A REGISTRATION STATEMENT WITH RESPECT THERETO IS EFFECTIVE
UNDER THE ACT AND ANY APPLICABLE STATE SECURITIES LAWS, OR (2) AN EXEMPTION FROM SUCH REGISTRATION EXISTS AND THE COMPANY RECEIVES AN
OPINION OF COUNSEL TO THE HOLDER OF SUCH SECURITIES, WHICH COUNSEL AND OPINION ARE SATISFACTORY TO THE COMPANY, THAT SUCH SECURITIES
MAY BE OFFERED, SOLD, PLEDGED, ASSIGNED OR TRANSFERRED IN THE MANNER CONTEMPLATED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT UNDER THE
ACT OR APPLICABLE STATE SECURITIES LAWS.

 

	Effective Date: _________	Void After: _________

 

NYIAX,
INC.

 

WARRANT
TO PURCHASE COMMON STOCK

 

NYIAX,
Inc., a Delaware corporation (the “Company”), for value received on ___________ (the “Effective Date”),
hereby issues to _______________________________________________________(the “Holder” or “Warrant Holder”)
this Warrant (the “Warrant”) to purchase ______ shares (each such share as from time to time adjusted as hereinafter
provided being a “Warrant Share” and all such shares being the “Warrant Shares”) of the Company’s
Common Stock (as defined below), at the Exercise Price (as defined below), as adjusted from time to time as provided herein, on or before
_________ five years from the Effective Date, or at the initial public offering (“IPO”) of the Company which every
event occurs first (the “Expiration Date”), all subject to the following terms and conditions. This Warrant has been
issued to the Holder pursuant to that certain Securities Purchase Agreement dated _______________ by and between the Company and the
Holder (the “Securities Purchase Agreement”).

 

As
used in this Warrant, (i) “Business Day” means any day other than Saturday, Sunday or any other day on which commercial
banks in the City of New York, New York, are authorized or required by law or executive order to close; (ii) “Common Stock”
means the common stock of the Company, par value $0.001 per share, including any securities issued or issuable with respect thereto or
into which or for which such shares may be exchanged for, or converted into, pursuant to any stock dividend, stock split, stock combination,
recapitalization, reclassification, reorganization or other similar event; (iii) “Exercise Price” means five ($5)
dollars per share of Common Stock, subject to adjustment as provided herein; (iv) “Trading Day” means any day on which
the Common Stock is traded (or available for trading) on its principal trading market; and (v) “Affiliate” means
any person that, directly or indirectly, through one or more intermediaries, controls, is controlled by, or is under common control with,
a person, as such terms are used and construed in Rule 144 promulgated under the Securities Act of 1933, as amended (the “Securities
Act”).

 

    
1  | P a g e

     

    

 

	1.	DURATION AND EXERCISE OF WARRANTS

 

(a)
Exercise Period. The Holder may exercise this Warrant in whole or in part on any Business Day on or before 5:00 P.M., Eastern
Time, on the Expiration Date, at which time this Warrant shall become void and of no value.

 

(b)
Exercise Procedures.

 

(i)
While this Warrant remains outstanding and exercisable in accordance with Section 1(a), the Holder may exercise this Warrant in whole
or in part at any time and from time to time by:

 

(A)
delivery to the Company of a duly executed copy of the Notice of Exercise attached as Exhibit A.

 

(B)
surrender of this Warrant to the Secretary of the Company at its principal offices or at such other office or agency as the Company may
specify in writing to the Holder; and

 

(C)
payment of the then-applicable Exercise Price per share multiplied by the number of Warrant Shares being purchased upon exercise of the
Warrant (such amount, the “Aggregate Exercise Price”) made in the form of cash, or by certified check, bank draft
or money order payable in lawful money of the United States of America.

 

(ii)
Upon the exercise of this Warrant in compliance with the provisions of this Section 1(b), the Company shall promptly issue and cause
to be delivered to the Holder a certificate for the Warrant Shares purchased by the Holder. Each exercise of this Warrant shall be effective
immediately prior to the close of business on the date (the “Date of Exercise”) that the conditions set forth in Section
1(b) have been satisfied, as the case may be. On the first Business Day following the date on which the Company has received each of
the Notice of Exercise and the Aggregate Exercise Price (the “Exercise Delivery Documents”), the Company shall transmit
an acknowledgment of receipt of the Exercise Delivery Documents to the Company’s transfer agent (the “Transfer Agent”).
On or before the third (3rd) Business Day following the date on which the Company has received all of the Exercise Delivery
Documents (the “Share Delivery Date”), the Company shall (X) provided that the Transfer Agent is participating in
The Depository Trust Company (“DTC”) Fast Automated Securities Transfer Program, upon the request of the Holder, credit
such aggregate number of shares of Common Stock to which the Holder is entitled pursuant to such exercise to the Holder’s or its
designee’s balance account with DTC through its Deposit Withdrawal Agent Commission system, or (Y) if the Transfer Agent is not
participating in the DTC Fast Automated Securities Transfer Program, issue and dispatch by overnight courier to the address as specified
in the Notice of Exercise, a certificate, registered in the Company’s share register in the name of the Holder or its designee,
for the number of shares of Common Stock to which the Holder is entitled pursuant to such exercise. Upon delivery of the Exercise Delivery
Documents, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect
to which this Warrant has been exercised, irrespective of the date of delivery of the certificates evidencing such Warrant Shares.

 

(c)
Partial Exercise. This Warrant shall be exercisable, either in its entirety or, from time to time, for part only of the number
of Warrant Shares referenced by this Warrant. If this Warrant is submitted in connection with any exercise pursuant to Section 1 and
the number of Warrant Shares represented by this Warrant submitted for exercise is greater than the actual number of Warrant Shares being
acquired upon such an exercise, then the Company shall as soon as practicable and in no event later than five (5) Business Days after
any exercise and at its own expense, issue a new Warrant of like tenor representing the right to purchase the number of Warrant Shares
purchasable immediately prior to such exercise under this Warrant, less the number of Warrant Shares with respect to which this Warrant
is exercised.

 

(d)
Disputes. In the case of a dispute as to the determination of the Exercise Price or the arithmetic calculation of the Warrant
Shares, the Company shall promptly issue to the Holder the number of Warrant Shares that are not disputed and resolve such dispute in
accordance with Section 16.

 

    
2  | P a g e

     

    

 

	2.	ISSUANCE OF WARRANT SHARES

 

(a)
The Company covenants that all Warrant Shares will, upon issuance in accordance with the terms of this Warrant, be (i) duly authorized,
fully paid and non-assessable, and (ii) free from all liens, charges and security interests, with the exception of claims arising through
the acts or omissions of any Holder and except as arising from applicable Federal and state securities laws.

 

(b)
The Company shall register this Warrant upon records to be maintained by the Company for that purpose in the name of the record holder
of such Warrant from time to time. The Company may deem and treat the registered Holder of this Warrant as the absolute owner thereof
for the purpose of any exercise thereof, any distribution to the Holder thereof and for all other purposes.

 

(c)
The Company will not, by amendment of its certificate of incorporation, by-laws or through any reorganization, transfer of assets, consolidation,
merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance
of any of the terms to be observed or performed hereunder by the Company, but will at all times in good faith assist in the carrying
out of all the provisions of this Warrant and in the taking of all action necessary or appropriate in order to protect the rights of
the Holder to exercise this Warrant, or against impairment of such rights.

 

	3.	ADJUSTMENTS OF EXERCISE PRICE, NUMBER AND
                                TYPE OF WARRANT SHARES

 

(a)
The Exercise Price and the number of shares purchasable upon the exercise of this Warrant shall be subject to adjustment from time to
time upon the occurrence of certain events described in this Section 3; provided, that notwithstanding the provisions of this
Section 3, the Company shall not be required to make any adjustment if and to the extent that such adjustment would require the Company
to issue a number of shares of Common Stock in excess of its authorized but unissued shares of Common Stock, less all amounts of Common
Stock that have been reserved for issue upon the conversion of all outstanding securities convertible into shares of Common Stock and
the exercise of all outstanding options, warrants and other rights exercisable for shares of Common Stock. If the Company does not have
the requisite number of authorized but unissued shares of Common Stock to make any adjustment, the Company shall use its commercially
best efforts to obtain the necessary stockholder consent to increase the authorized number of shares of Common Stock to make such an
adjustment pursuant to this Section 3.

 

(i)
Subdivision or Combination of Stock. In case the Company shall at any time subdivide (whether by way of stock dividend, stock
split or otherwise) its outstanding shares of Common Stock into a greater number of shares, the Exercise Price in effect immediately
prior to such subdivision shall be proportionately reduced and the number of Warrant Shares shall be proportionately increased, and conversely,
in case the outstanding shares of Common Stock of the Company shall be combined (whether by way of stock combination, reverse stock split
or otherwise) into a smaller number of shares, the Exercise Price in effect immediately prior to such combination shall be proportionately
increased and the number of Warrant Shares shall be proportionately decreased. The Exercise Price and the Warrant Shares, as so adjusted,
shall be readjusted in the same manner upon the happening of any successive event or events described in this Section 3(a)(i).

 

(ii)
Dividends in Stock, Property, Reclassification. If at any time, or from time to time, all of the holders of Common Stock (or any
shares of stock or other securities at the time receivable upon the exercise of this Warrant) shall have received or become entitled
to receive, without payment therefore:

 

(A)
any shares of stock or other securities that are at any time directly or indirectly convertible into or exchangeable for Common Stock,
or any rights or options to subscribe for, purchase or otherwise acquire any of the foregoing by way of dividend or other distribution,
or

 

    
3  | P a g e

     

    

 

(B)
additional stock or other securities or property (including cash) by way of spin-off, split-up, reclassification, combination of
shares or similar corporate rearrangement (other than shares of Common Stock issued as a stock split or adjustments in respect of which
shall be covered by the terms of Section 3(a)(i) above), then and in each such case, the Exercise Price and the number of Warrant Shares
to be obtained upon exercise of this Warrant shall be adjusted proportionately, and the Holder hereof shall, upon the exercise of this
Warrant, be entitled to receive, in addition to the number of shares of Common Stock receivable thereupon, and without payment of any
additional consideration therefor, the amount of stock and other securities and property (including cash in the cases referred to above)
that such Holder would hold on the date of such exercise had such Holder been the holder of record of such Common Stock as of the date
on which holders of Common Stock received or became entitled to receive such shares or all other additional stock and other securities
and property. The Exercise Price and the Warrant Shares, as so adjusted, shall be readjusted in the same manner upon the happening of
any successive event or events described in this Section 3(a)(ii).

 

(iii)
Reorganization, Reclassification, Consolidation, Merger or Sale. If any recapitalization, reclassification or reorganization of
the capital stock of the Company, or any consolidation or merger of the Company with another corporation, or the sale of all or substantially
all of its assets or other transaction shall be effected in such a way that holders of Common Stock shall be entitled to receive stock,
securities, or other assets or property (an “Organic Change”), then, as a condition of such Organic Change, lawful
and adequate provisions shall be made by the Company whereby the Holder hereof shall thereafter have the right to purchase and receive
(in lieu of the shares of the Common Stock of the Company immediately theretofore purchasable and receivable upon the exercise of the
rights represented by this Warrant) such shares of stock, securities or other assets or property as may be issued or payable with respect
to or in exchange for a number of outstanding shares of such Common Stock equal to the number of shares of such stock immediately theretofore
purchasable and receivable assuming the full exercise of the rights represented by this Warrant. In the event of any Organic Change,
appropriate provision shall be made by the Company with respect to the rights and interests of the Holder of this Warrant to the end
that the provisions hereof (including, without limitation, provisions for adjustments of the Exercise Price and of the number of shares
purchasable and receivable upon the exercise of this Warrant) shall thereafter be applicable, in relation to any shares of stock, securities
or assets thereafter deliverable upon the exercise hereof. The Company will not affect any such consolidation, merger or sale unless,
prior to the consummation thereof, the successor corporation (if other than the Company) resulting from such consolidation or merger
or the corporation purchasing such assets shall assume by written instrument reasonably satisfactory in form and substance to the Holder
executed and mailed or delivered to the registered Holder hereof at the last address of such Holder appearing on the books of the Company,
the obligation to deliver to such Holder such shares of stock, securities or assets as, in accordance with the foregoing provisions,
such Holder may be entitled to purchase.

 

If
there is an Organic Change, then the Company shall cause to be mailed to the Holder at its last address as it shall appear on the books
and records of the Company, at least 10 calendar days before the effective date of the Organic Change, a notice stating the date on which
such Organic Change is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock
of record shall be entitled to exchange their shares for securities, cash, or other property delivered upon such Organic Change; provided,
that the failure to mail such notice or any defect therein or in the mailing thereof shall not affect the validity of the corporate action
required to be specified in such notice. The Holder is entitled to exercise this Warrant during the 10-day period commencing on the date
of such notice to the effective date of the event triggering such notice. In any event, the successor corporation (if other than the
Company) resulting from such consolidation or merger or the corporation purchasing such assets shall be deemed to assume such obligation
to deliver to such Holder such shares of stock, securities or assets even in the absence of a written instrument assuming such obligation
to the extent such assumption occurs by operation of law.

 

    
4  | P a g e

     

    

 

(b)
Certificate as to Adjustments. Upon the occurrence of each adjustment or readjustment pursuant to this Section 3, the Company
at its expense shall promptly compute such adjustment or readjustment in accordance with the terms hereof and furnish to each Holder
of this Warrant a certificate setting forth such adjustment or readjustment and showing in detail the facts upon which such adjustment
or readjustment is based. The Company shall promptly furnish or cause to be furnished to such Holder a like certificate setting forth:
(i) such adjustments and readjustments; and (ii) the number of shares and the amount, if any, of other property which at the time would
be received upon the exercise of the Warrant.

 

(c)
Certain Events. If any event occurs as to which the other provisions of this Section 3 are not strictly applicable but the lack
of any adjustment would not fairly protect the purchase rights of the Holder under this Warrant in accordance with the basic intent and
principles of such provisions, or if strictly applicable would not fairly protect the purchase rights of the Holder under this Warrant
in accordance with the basic intent and principles of such provisions, then the Company’s Board of Directors will, in good faith,
make an appropriate adjustment to protect the rights of the Holder; provided, that no such adjustment pursuant to this Section
3(c) will increase the Exercise Price or decrease the number of Warrant Shares as otherwise determined pursuant to this Section 3.

 

	4.	INTENTIONALLY LEFT BLANK

 

	5.	TRANSFERS AND EXCHANGES OF WARRANT AND WARRANT
                                SHARES.

 

(a)
Registration of Transfers and Exchanges. Subject to Section 5(c), upon the Holder’s surrender of this Warrant, with a duly executed
copy of the Form of Assignment attached as Exhibit B, to the Secretary of the Company at its principal offices or at such other office
or agency as the Company may specify in writing to the Holder, the Company shall register the transfer of all or any portion of this
Warrant. Upon such registration of transfer, the Company shall issue a new Warrant, in substantially the form of this Warrant, evidencing
the acquisition rights transferred to the transferee and a new Warrant, in similar form, evidencing the remaining acquisition rights
not transferred, to the Holder requesting the transfer.

 

(b)
Warrant Exchangeable for Different Denominations. The Holder may exchange this Warrant for a new Warrant or Warrants, in substantially
the form of this Warrant, evidencing in the aggregate the right to purchase the number of Warrant Shares which may then be purchased
hereunder, each of such new Warrants to be dated the date of such exchange and to represent the right to purchase such number of Warrant
Shares as shall be designated by the Holder. The Holder shall surrender this Warrant with duly executed instructions regarding such re-certification
of this Warrant to the Secretary of the Company at its principal offices or at such other office or agency as the Company may specify
in writing to the Holder.

 

(c)
(c)Restrictions on Transfers. This Warrant may not be transferred at any time without (i) registration under the Securities Act
or (ii) an exemption from such registration and a written opinion of legal counsel addressed to the Company that the proposed transfer
of the Warrant may be effected without registration under the Securities Act, which opinion will be in form and from counsel reasonably
satisfactory to the Company.

 

(d)
Permitted Transfers and Assignments. Notwithstanding any provision to the contrary in this Section 5, the Holder may transfer, with or
without consideration, this Warrant or any of the Warrant Shares (or a portion thereof) to the Holder’s Affiliates (as such term
is defined under Rule 144 of the Securities Act) without obtaining the opinion from counsel that may be required by Section 5(c)(ii),
provided, that the Holder delivers to the Company and its counsel certification, documentation, and other assurances reasonably required
by the Company’s counsel to enable the Company’s counsel to render an opinion to the Company’s Transfer Agent that
such transfer does not violate applicable securities laws.

 

    
5  | P a g e

     

    

 

	6.	MUTILATED OR MISSING WARRANT CERTIFICATE.

 

If
this Warrant is mutilated, lost, stolen or destroyed, upon request by the Holder, the Company will, at its expense, issue, in exchange
for and upon cancellation of the mutilated Warrant, or in substitution for the lost, stolen or destroyed Warrant, a new Warrant, in substantially
the form of this Warrant, representing the right to acquire the equivalent number of Warrant Shares; provided, that, as a prerequisite
to the issuance of a substitute Warrant, the Company may require satisfactory evidence of loss, theft or destruction as well as an indemnity
from the Holder of a lost, stolen or destroyed Warrant.

 

	7.	PAYMENT OF TAXES.

 

The
Company will pay all transfer and stock issuance taxes attributable to the preparation, issuance and delivery of this Warrant and the
Warrant Shares (and replacement Warrants) including, without limitation, all documentary and stamp taxes; provided, however,
that the Company shall not be required to pay any tax in respect of the transfer of this Warrant, or the issuance or delivery of certificates
for Warrant Shares or other securities in respect of the Warrant Shares to any person or entity other than to the Holder.

 

	8.	FRACTIONAL WARRANT SHARES.

 

No
fractional Warrant Shares shall be issued upon exercise of this Warrant. The Company, in lieu of issuing any fractional Warrant Share,
shall round up the number of Warrant Shares issuable to nearest whole share.

 

	9.	NO STOCK RIGHTS AND LEGEND.

 

No
holder of this Warrant, as such, shall be entitled to vote or be deemed the holder of any other securities of the Company that may at
any time be issuable on the exercise hereof, nor shall anything contained herein be construed to confer upon the holder of this Warrant,
as such, the rights of a stockholder of the Company or the right to vote for the election of directors or upon any matter submitted to
stockholders at any meeting thereof, or give or withhold consent to any corporate action or to receive notice of meetings or other actions
affecting stockholders (except as provided herein), or to receive dividends or subscription rights or otherwise (except as provide herein).

 

    
6  | P a g e

     

    

 

Each
certificate for Warrant Shares initially issued upon the exercise of this Warrant, and each certificate for Warrant Shares issued to
any subsequent transferee of any such certificate, shall be stamped or otherwise imprinted with a legend in substantially the following
form:

 

“THE
SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”),
OR ANY STATE SECURITIES LAWS, AND NEITHER SUCH SECURITIES NOR ANY INTEREST THEREIN MAY BE OFFERED, SOLD, PLEDGED, ASSIGNED OR OTHERWISE
TRANSFERRED UNLESS (1) A REGISTRATION STATEMENT WITH RESPECT THERETO IS EFFECTIVE UNDER THE ACT AND ANY APPLICABLE STATE SECURITIES
LAWS, OR (2) AN EXEMPTION FROM SUCH REGISTRATION EXISTS AND THE COMPANY RECEIVES AN OPINION OF COUNSEL TO THE HOLDER OF SUCH SECURITIES,
WHICH COUNSEL AND OPINION ARE REASONABLY SATISFACTORY TO THE COMPANY, THAT SUCH SECURITIES MAY BE OFFERED, SOLD, PLEDGED, ASSIGNED OR
TRANSFERRED IN THE MANNER CONTEMPLATED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT OR APPLICABLE STATE SECURITIES LAWS.”

 

	10.	INTENTIONALLY LEFT BLANK.

 

	11.	NOTICES.

 

All
notices, consents, waivers, and other communications under this Warrant must be in writing and will be deemed given to a party when (a)
delivered to the appropriate address by hand or by nationally recognized overnight courier service (costs prepaid); (b) sent by facsimile
or e-mail with confirmation of transmission by the transmitting equipment; (c) received or rejected by the addressee, if sent by certified
mail, return receipt requested, if to the registered Holder hereof; or (d) seven days after the placement of the notice into the mails
(first class postage prepaid), to the Holder at the address, facsimile number, or e-mail address furnished by the registered Holder to
the Company, or if to the Company, to it at:

 

	 	NYIAX, Inc.
	 	244 5th Avenue, Suite 2669 New York, NY 10001 

Attention: Mark Grinbaum

 Email: mgrinbaum@nyiax.com

 

	12.	SEVERABILITY.

 

If
a court of competent jurisdiction holds any provision of this Warrant invalid or unenforceable, the other provisions of this Warrant
will remain in full force and effect. Any provision of this Warrant held invalid or unenforceable only in part or degree will remain
in full force and effect to the extent not held invalid or unenforceable.

 

	13.	BINDING EFFECT.

 

This
Warrant shall be binding upon and inure to the sole and exclusive benefit of the Company, its successors and assigns, the registered
Holder or Holders from time to time of this Warrant and the Warrant Shares.

 

	14.	SURVIVAL OF RIGHTS AND DUTIES.

 

This
Warrant shall terminate and be of no further force and effect on the earlier of 5:00 P.M., Eastern Time, on the Expiration Date or the
date on which this Warrant has been exercised in full.

 

	15.	GOVERNING LAW.

 

This
Warrant will be governed by and construed under the laws of the State of Delaware without regard to conflicts of laws principles that
would require the application of any other law.

 

    
7  | P a g e

     

    

 

	16.	DISPUTE RESOLUTION.

 

In
the case of a dispute as to the determination of the Exercise Price or the arithmetic calculation of the Warrant Shares, the Company
shall submit the disputed determinations or arithmetic calculations via facsimile within two (2) Business Days of receipt of the Notice
of Exercise giving rise to such dispute, as the case may be, to the Holder. If the Holder and the Company are unable to agree upon such
determination or calculation of the Exercise Price or the Warrant Shares within three Business Days of such disputed determination or
arithmetic calculation being submitted to the Holder, then the Company shall, within two Business Days, submit via facsimile (a) the
disputed determination of the Exercise Price to an independent, reputable investment bank selected by the Company and approved by the
Holder or (b) the disputed arithmetic calculation of the Warrant Shares to the Company’s independent, outside accountant. The Company
shall cause at its expense the investment bank or the accountant, as the case may be, to perform the determinations or calculations and
notify the Company and the Holder of the results no later than ten (10) Business Days from the time it receives the disputed determinations
or calculations. Such investment bank’s or accountant’s determination or calculation, as the case may be, shall be binding
upon all parties absent demonstrable error.

 

	17.	NOTICES OF RECORD DATE.

 

Upon
(a) any establishment by the Company of a record date of the holders of any class of securities for the purpose of determining the holders
thereof who are entitled to receive any dividend or other distribution, or right or option to acquire securities of the Company, or any
other right, or (b) any capital reorganization, reclassification, recapitalization, merger or consolidation of the Company with or into
any other corporation, any transfer of all or substantially all the assets of the Company, or any voluntary or involuntary dissolution,
liquidation or winding up of the Company, or the sale, in a single transaction, of a majority of the Company’s voting stock (whether
newly issued, or from treasury, or previously issued and then outstanding, or any combination thereof), the Company shall mail to the
Holder at least ten (10) Business Days, or such longer period as may be required by law, prior to the record date specified therein,
a notice specifying (i) the date established as the record date for the purpose of such dividend, distribution, option or right and a
description of such dividend, option or right, (ii) the date on which any such reorganization, reclassification, transfer, consolidation,
merger, dissolution, liquidation or winding up, or sale is expected to become effective and (iii) the date, if any, fixed as to when
the holders of record of Common Stock shall be entitled to exchange their shares of Common Stock for securities or other property deliverable
upon such reorganization, reclassification, transfer, consolation, merger, dissolution, liquidation or winding up.

 

	18.	RESERVATION OF SHARES.

 

The
Company shall reserve and keep available out of its authorized but unissued shares of Common Stock for issuance upon the exercise of
this Warrant, free from pre-emptive rights, such number of shares of Common Stock for which this Warrant shall from time to time be exercisable.
The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein
without violation of any applicable law or regulation. Without limiting the generality of the foregoing, the Company covenants that it
will use commercially reasonable efforts to take all such action as may be necessary or appropriate in order that the Company may validly
and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and use commercially reasonable efforts
to obtain all such authorizations, exemptions or consents, including but not limited to consents from the Company’s stockholders
or Board of Directors or any public regulatory body, as may be necessary to enable the Company to perform its obligations under this
Warrant.

 

	19.	NO THIRD-PARTY RIGHTS.

 

This
Warrant is not intended, and will not be construed, to create any rights in any parties other than the Company and the Holder, and no
person or entity may assert any rights as third-party beneficiary hereunder.

 

[remainder
of page intentionally left blank]

 

    
8  | P a g e

     

    

 

IN
WITNESS WHEREOF, the Company has caused this Warrant to be duly executed as of the date first set forth above.

 

	 	NYIAX, INC.
	 	 
	 	By:	 
	 	Name:	Mark Grinbaum
	 	Title:	Executive Vice President and Treasurer

  

    
9  | P a g e

     

    

 

EXHIBIT
C: NEW INVESTORS

 

EXHIBIT
A

NOTICE OF EXERCISE

 

(To
be executed by the Holder of Warrant if such Holder desires to exercise Warrant) To NYIAX, Inc.:The undersigned hereby irrevocably
elects to exercise this Warrant and to purchase thereunder,  ___ full shares of NYIAX, Inc.’s common stock issuable
upon exercise of the Warrant and delivery of $  __ (in cash as provided for in the foregoing Warrant) and any applicable
taxes payable by the undersigned pursuant to such Warrant; and

 

The
undersigned requests that certificates for such shares be issued in the name of:

  

	 	(Please
    print name, address and social security or federal employer	 
	 	identification number (if
    applicable))	 

 

If
the shares issuable upon this exercise of the Warrant are not all of the Warrant Shares which the Holder is entitled to acquire upon
the exercise of the Warrant, the undersigned requests that a new Warrant evidencing the rights not so exercised be issued in the name
of and delivered to:

 

	 	(Please
    print name, address and social security or	 
	 	federal employer identification
    number (if applicable))	 

 

	 	Name of Holder
    (print): __________________________
	 	(Signature): ___________________________________
	 	(By:) ________________________________________
	 	(Title:) _______________________________________
	 	Dated: _______________________________________

 

    
10  | P a g e

     

    

 

 

 

EXHIBIT
B

 

FORM
OF ASSIGNMENT

 

FOR
VALUE RECEIVED, ____ hereby sells, assigns and transfers to each assignee set forth below all of the rights of the
undersigned under the Warrant (as defined in and evidenced by the attached Warrant) to acquire the number of Warrant Shares set
opposite the name of such assignee below and in and to the foregoing Warrant with respect to said acquisition rights and the shares
issuable upon exercise of the Warrant:

 

	Name
    of Assignee	 	Address	 	Number
    of Shares
	 	 	 	 	 
	 	 	 	 	 
	 	 	 	 	 
	 	 	 	 	 

 

If
the total of the Warrant Shares are not all of the Warrant Shares evidenced by the foregoing Warrant, the undersigned requests that a
new Warrant evidencing the right to acquire the Warrant Shares not so assigned be issued in the name of and delivered to the undersigned.

 

	 	Name of Holder
    (print): __________________________
	 	(Signature): ___________________________________
	 	(By:) ________________________________________
	 	(Title:) _______________________________________
	 	Dated: _______________________________________

 

    
11  | P a g eExhibit 10.34

 

EMPLOYMENT AGREEMENT AND GENERAL RELEASE

 

THIS AGREEMENT
AND GENERAL RELEASE (the “Agreement”) is made by and between Carolina Abenante, on behalf of herself, her agents, assignees,
successors, heirs, executors, administrators, beneficiaries, trustees and power of attorney (collectively, “Executive”), and
NYIAX, Inc., its current and former officers, directors, affiliates, subsidiaries, insurers, successors and assigns (individually and
collectively “NYIAX”). Executive and NYIAX shall be collectively referred to herein as the “Parties.”

 

For good and
valuable consideration, the receipt and sufficiency of which are acknowledged hereby, and in consideration of the mutual covenants and
undertakings set forth herein, the Parties agree as follows:

 

1. Role and Responsibilities.
Executive will serve as Co-Founder, Vice-Chairperson/Director, Chief Strategy Officer and Chief
Evangelist. All of Executive’s day-to-day activities are subject to approval by the COO, Chris Hogan, and the Board of Directors of
NYIAX (the “Board”). Executive agrees that the Company’s responsibilities of the General Counsel’s Office will be handled
by outside counsel, to be determined by Chairman of the Board or designate. As Chief Strategy Officer and Chief Evangelist,
Executive agrees to be responsible for corporate strategy, reporting directly to the Board guiding the Company’s future offerings,
extension of the Company intellectual property and working with, COO (Chris Hogan), and the Board representative to corporate
strategy (Tom O’Neill). In addition, as Chief Strategy Officer and Chief Evangelist, Executive is responsible for corporate public
relations and will work with COO (Chris Hogan) and will prepare a corporate public relations (“CPR”) plan, with the
assistance of COO (Chris Hogan) and CFO (Bill Feldman) that includes the following: (i) NFT/Adweek; (ii) Cannes; (iii) Web summit;
and (iv) Outside agency relations (v) public facing of the company in regard to matters of public relations, and (vi) any
other duties the COO requests from time to time (t). Executive agrees to attend the marketing calls as required, including, (i)
management group: Chris Hogan & outside agency; and (ii) other company calls as required by Chris Hogan. Executive will continue
to serve on the Company Board of Directors and be Vice Chairperson of the Board.

 

 2.   Compensation.
Executive will be paid a salary of $255,000 per year, payable on the Company’s standard payroll dates, less all applicable
withholdings and deductions which will be accounted in the TriNet System, similar PEO or other payroll system the Company may use
from time to time. For the period of May 16, 2022 through July 15, 2022, Executive’s salary will be reduced to $100,000 per year.
Executive is entitled to medical, additional healthcare and any executive or employee 401K plan, and participate in any profit
sharing or any other plan provided for any of the executive team of the Company, if any. Discretionary bonus of 20% per year based
on review by the direct supervisor and final decision in the Compensation Committee’s sole discretion.

 

3. Expenses - Company shall pay or
reimburse Executive for all necessary and reasonable expenses incurred or paid by Employee in connection with the performance of
Executive’s duties under this Agreement and in accordance with the Company’s expense reimbursement policies at that time. The
Executive must receive prior written consent from Executive’s direct supervisor and furnish expense statements or vouchers or such
other supporting information as it from time-to-time requests evidencing the nature of such expense, and, if appropriate, the
payment thereof by Executive, and otherwise in accordance with Company procedures at that time.

 

    1

     

    

 

 4. Equity. Executive is the owner of 1,000,000 shares (founder shares) 100,000 of the founder shares of 1,000,000 were gifted to Chris Hogan June 2021; 160,000 Options awarded 11/16/2021, the strike price of $4.40, fully vested; and 50,000 Options awarded 1/13/2022, the strike price of $5.00, all fully vested. As of this date, the Executive does not own any additional shares, options, or other equity in any form. Executive acknowledges and agrees that the only payments and benefits for current and any and all past services, including but not limited to payments for any bonuses, severances, salary, and other compensation, that is entitled to receive in the future are those specified in this Agreement.

 

5. Termination. Term
of Employment. Executive’s employment under this Agreement shall commence on the Effective Date hereof and continue for a period
of one (1) year (the “Initial Term”), or until otherwise terminated in accordance with the provisions of this
Section 5. This Agreement shall automatically renew for successive one (1)-year terms (each, if any, a “Renewal
Term”) unless earlier terminated in accordance with the provisions of this Section 5, or unless either Party provides the
other Party with thirty (30) days written notice of non-renewal prior to the end of the Initial Term or then-current Renewal Term or
upon a majority vote of the independent members of the Board and the chairman of the Board vote to provide the Executive with six
months notice of termination after the Initial Term. For purposes of this Agreement, the period of time from the date hereof until
the termination or non-renewal of this Agreement, including the Initial Term and any Renewal Term, will be referred to herein as the
“Agreement Term.” The date this Agreement terminates shall be referred to as the “Termination Date”.

 

(a) Termination
by the Company for Death or Disability. Notwithstanding anything to the contrary in section 5, the Company may terminate this
Agreement immediately without notice or penalty upon the occurrence of one of the following conditions or events:

 

 (b) the death of the Executive; or

 

(c) The Company may
terminate the Executive’s employment if she is disabled and unable to perform the essential functions of the Executive’s then
existing position or positions under this Agreement with or without reasonable accommodation for a period of 90 days (which need not
be consecutive) in any 12-month period. If any question shall arise as to whether during any period the Executive is disabled so as
to be unable to perform the essential functions of the Executive’s then existing position or positions with or without reasonable
accommodation, the Executive may, and at the request of the Company shall, submit to the Company a certification in reasonable
detail by a physician selected by the Company to whom the Executive or the Executive’s guardian has no reasonable objection as to
whether the Executive is so disabled or how long such disability is expected to continue, and such certification shall for the
purposes of this Agreement be conclusive of the issue. The Executive shall cooperate with any reasonable request of the physician in
connection with such certification. If such question shall arise and the Executive shall fail to submit such certification, the
Company’s determination of such issue shall be binding on the Executive.

 

    2

     

    

 

6. Termination by the
Company for Cause. Notwithstanding anything to the contrary in this section 6, the Company may terminate this Agreement
immediately without notice or penalty upon the occurrence of one of the following conditions or events (each being for
“Cause”):

 

(a) Any
material breach by Executive of the terms of this Agreement which is not cured by Executive within thirty (30) days after Executive
is notified in writing of such breach by the Company;

 

(b) The quality of
Executive’s work is substandard, as reasonably determined by the Company, and Executive has not been cured within thirty (30)
working days, meaning not counting any days Executive is on paid time off under Section 1, after receiving written notice
from Company of such substandard work;

 

(c) Executive is convicted
of or pleads guilty or nolo contendere to a felony of embezzlement, fraud, theft, or dishonesty;

 

(d) Gross negligence or
willful misconduct of Executive in connection with the performance of Executive’s duties under this Agreement (which includes but is
not limited to, willful disregard of Board instructions); or material breach of a company policy; or

 

(e)
Executive engages in misconduct that brings or could bring discredit upon the Company or makes Executive’s continued presence as
an employee of the Company, as reasonably determined by the Company, materially detrimental to the Company, its employees, its investors,
stockholders/shareholders, its customers, or its reputation.

 

7. Termination by
Executive for Good Reason. The Executive may terminate this Agreement (i) for any reason or no reason at all and without penalty
upon the delivery of one hundred twenty (120) days’ written notice to the Company; or (ii) immediately without notice or penalty for
Good Reason. “Good Reason” shall mean the Company materially breaches this Agreement by failing to pay any
compensation due to Executive under Section 2 of this Agreement and such breach(es) is/are not promptly cured within sixty
(60) business days following written notice to the Company specifically describing the breach(es).

 

8. Compensation Due upon Termination.

 

(a) In the event this
Agreement is terminated, Executive shall be entitled to the compensation which Executive has earned and not yet collected pursuant
to this Agreement up to the date of termination, including continuation of benefits until such date and reimbursement of expenses
properly incurred and documented through the Termination Date. Compensation following termination shall be paid by the Company in
the ordinary course of its payroll practices. Except as otherwise provided to the contrary in this Section 8 or as required under
applicable law, upon termination of this Agreement, the Company shall have no obligation to make any payments to Executive for
additional salary or benefits.

 

    3

     

    

 

 9. Time Off. The Executive shall be entitled all time off, including paid time off, as required by law. Executive shall also be entitled to four (4) weeks of paid time off on an annual basis during the Agreement Term, and such other holidays in accordance with the Company’s applicable policies and procedures as in effect from time to time and local, state, or federal law. Executive shall take all vacation and leave so as to minimize disruptions with Executive’s duties.

 

 10. Executive’s Outside Roles.

 

(a)
The Executive can from time to time have projects and work for other businesses through consulting projects outside of the Company.
The Executive may sit on Boards of outside companies both private or public which are in any industry or the industry in which the Company
does business. Where there is a conflict of interest between the Company and the consulting project that the Executive or the Board of
an outside company, then the Executive shall notify the Company for a review of the project or Board and the Company shall make, in its
sole reasonable discretion, a determination if the Executive should remain on the Board or continue the consulting project, which shall
be at the sole discretion of the Company Board. Executive shall hold the Company harmless for non-Company activity. The Executive
shall indemnify and hold the Company, its employees, and shareholders harmless for all activity that she performs in the scope of this
section.

 

11. Release
of all Claims Against NYIAX. As a material inducement to NYIAX to enter into this Agreement and in consideration of the
promises, payments, and other benefits described above, Executive, on behalf of herself and any representatives, agents, estate,
heirs, successors and assigns, and with full understanding of the contents and legal effect of this Agreement and having had the
opportunity to consult with counsel, releases and discharges NYIAX, and its shareholders, officers, directors, supervisors, members,
managers, employees, agents, representatives, attorneys, insurers, parent companies, divisions, subsidiaries, affiliates,
consultants, investors, and all employee benefit plans sponsored by or contributed to by NYIAX and all related entities and persons
of any kind or nature and its and their predecessors, successors, heirs, executors, administrators, and assigns (collectively, the
“Released Parties”) from any and all claims, actions, causes of action, grievances, suits, charges, or complaints of any
kind or nature whatsoever, that Executive ever had or now has, whether known or unknown, suspected or unsuspected, and whether
arising in tort, contract, statute, or equity, before any federal, state, local, or private court, agency, arbitrator, mediator, or
other entity, regardless of the relief or remedy. Such claims include, without limitation, any claims under the Fair Labor Standards
Act; Title VII of the Civil Rights Act of 1964, as amended; the Civil Rights Act of 1866, as amended by the Civil Rights Act of 1991
(42 U.S.C. § 1981); the Rehabilitation Act of 1973, as amended; the Employee Retirement Income Security Act of 1974, as
amended; the Americans with Disabilities Act, as amended; the Family and Medical Leave Act; the Genetic Information
Nondiscrimination Act of 2008; the Worker Adjustment and Retraining Notification Act; the Equal Pay Act; the Age Discrimination in
Employment Act (“ADEA”); New York State Human Rights Law; the New York Labor Law (including but not limited to the New
York State Pay Equity Law and the New York State Worker Adjustment and Retraining Notification Act, all provisions prohibiting
discrimination and retaliation, whistleblower claims, and all provisions regulating wage and hour law); the New York State
Correction Law; the New York State Civil Rights Law; Section 125 of the New York Workers’ Compensation Law; the New York City Human
Rights Law; any and all other federal, state or local statutes, including the laws of New Jersey; and any other statutory claim,
tort claim, employment, or other contract or implied contract claim, or common law claim for wrongful discharge, breach of contract,
breach of an implied covenant of good faith and fair dealing, defamation, invasion of privacy, or any other claim, arising out of or
in connection with or involving Executive’s employment with NYIAX. The sole exceptions to this section 11 are (i) claims Executive
may have against Westpark Capital Inc. its parent company heirs, assigns, orsuccessors and or Univest Securities LLC its parent
company heirs, assigns or successors with respect solely to actions of Executive’s previous or current personal broker, investment
advisor or personal brokerage account in connection to Westpark Capital, Inc. or Univest Securities LLC or their parent companies or
assigns brought before FINRA or any court of competent jurisdiction, any personal loans provided to any Released Party or (ii)
participation in a future stockholder derivative suit, if filed by another party against NYIAX.

 

    4

     

    

 

12. Release of all
Claims Against Executive. As a material inducement to Executive to enter into this Agreement and in consideration of the
promises described in this Agreement, NYIAX releases Executive from any and all claims, actions, causes of action, grievances,
suits, charges, or complaints of any kind or nature whatsoever, that Executive ever had or now has, whether known suspected, and
whether arising in tort, contract, before any federal, state, local, or private court, agency, arbitrator, mediator, or other
entity, regardless of the relief or remedy, including, but not limited to, any statutory claim, tort claim, employment, or other
contract or implied contract claim, or common law claim for wrongful discharge, breach of contract, breach of an implied covenant of
good faith and fair dealing, arising out of or in connection with or involving Executive’s employment with NYIAX.

 

13. Covenant Not to
Sue. The Parties agree on behalf of herself / itself and any representatives, agents, estate, heirs, successors and assigns,
agrees not to bring, file, claim, sue or cause, assist, or permit to be brought, filed, or claimed any action, cause of action or
proceeding regarding or in any way related to any of the claims described in Section 11 and 12 above, and further agrees that this
Agreement is a bar to any such claim, action, cause of action or proceeding. The Parties further agree not to participate in, seek
to recover in, accept any portion of any recovery from, or assist in any action, cause of action, proceeding, complaint, litigation
or investigation by other persons or entities against any of the Released Parties and/or Executive, except as required by law or
specifically provided in section exceptions specified in section 11 above.

 

14. Permitted Activities.
The Parties releases above cover only those claims that arose prior to the execution of this Agreement. Execution of this Agreement does
not bar any claim that arises hereafter, including (without limitation) a claim for breach of this Agreement. Additionally, nothing in
this Agreement, including its non-disclosure and non-disparagement provisions, precludes the Parties from reporting possible violations
of federal law or regulation, or participating in any investigation or proceeding, to or before any federal, state or local agency or
governmental body, including the Securities and Exchange Commission, the Financial Industry Regulatory Authority (FINRA), and the EEOC
(“Government Agencies”) or from making other disclosures that are protected under the whistleblower provisions of federal law
or regulation without prior authorization from or any notice. However, while Executive may file a charge and participate in any such
proceeding, by signing this Agreement, Executive waives any right to bring a lawsuit against the Released Parties, and waives any right
to any individual monetary recovery in any such proceeding or lawsuit; provided, however, notwithstanding anything to the contrary in
this Agreement, in no way shall limit Abenante’s right to receive an award for information provided to any Government Agencies

 

15. No Pending or
Future Lawsuits. Executive represents that she has no lawsuits, claims, actions or proceedings pending in her name, on her
behalf or on behalf of any other person or entity, against NYIAX or any of the Released Parties. Executive also represents that she
does not intend to and will not bring any claims or proceedings on her own behalf or on behalf of any other person or entity against
NYIAX or any of the Released Parties.

 

16. Non-Disclosure.
It is the intention of the Parties, and an essential part of this Agreement, that this Agreement itself and the discussions leading
up to its execution, and any of its terms and conditions, shall not be disclosed by either Party to anyone, including, but not
limited to, any current or former employee of NYIAX, or in any book, diary or journal, or on any social media or other website.
Except as may be required by law, neither Party shall directly or indirectly publish, disseminate, disclose, or cause or permit to
be published, disseminated, or disclosed to any individual or entity any information relating to the content of this Agreement,
including, without limitation, the fact or amount of the consideration provided herein. This Paragraph shall not be construed,
however, to prevent either Party from disclosing information to a spouse, immediate family, any attorney, accountant, tax preparer
or tax or financial advisors with whom it may consult for the purpose of obtaining professional advice or services; any governmental
taxing authority; or to any court, administrative agency or officer, or judicial officer, pursuant to any valid subpoena or court or
administrative order, provided, however, that prior to disclosing any such information, the Party disclosing such information shall
advise any such person to whom it intends to disclose the information (other than taxing authorities) that such information is
confidential and may not be disclosed by such person, except in response to a valid subpoena or judicial, agency or administrative
order. In addition, NYIAX may disclose the terms on a need to know basis for business reasons to implement the terms of the
Agreement.

 

    5

     

    

 

17. Non-Disparagement.
Executive agrees that she will not make, or cause to be made, any disparaging statement or communicate any information (whether
orally, in writing or electronically) that is disparaging of the Released Parties, including, without limitation, making any such
statements or communications to any persons, including but not limited to customers, partners, news organizations, trade and
professional organizations, governmental organizations, licensing boards, or on social media and/or social networking sites, other
than with respect to the potential claims specified as exceptions to paragraph 11. The Company agrees that it will not make any
Company statements that are disparaging statements (orally or in writing) about you, except as required by law or by a court of
competent jurisdiction or as necessary to refute a disparaging comment made about the Company or its officers and directors by you.
The Company further agrees to issue a press release agreed to by Company and Executive that Executive is taking on new
responsibilities such as Chief Strategy Officer and Chief Evangelist of NYIAX as well Founder and Vice Chairperson of the Board.

 

18. Remedies,
Cooperation. Executive agrees to reasonably assist and cooperate with NYIAX in the defense or prosecution of any claims or
actions concerning the time period of her employment asserted by or made against any of the Released Parties, or in connection with
any ongoing or future investigation or dispute or claim of any kind involving NYIAX, including any proceeding before any arbitral,
administrative, judicial, legislative, or other body or agency, including testifying in any proceeding to the extent such claims,
investigations or proceedings relate to services performed or required to be performed by Executive, pertinent knowledge possessed
by Executive, or any act or omission by Executive. Executive agrees to perform all acts and execute and deliver any documents that
may be reasonably necessary to carry out the provisions of this Paragraph. NYIAX shall reimburse Executive for any reasonable
out-of-pocket travel and accommodation-related expenses incurred by her as a result of such cooperation, and such cooperation shall
be subject to her reasonable professional availability. Nothing in this Paragraph is intended to preclude Executive from testifying
truthfully if compelled by legal or administrative process to testify as a witness in any legal proceeding.

 

19. Severability.
The provisions of this Agreement are severable. If any provision of this Agreement is held invalid or unenforceable, such provision
shall be deemed deleted from this Agreement and such invalidity or unenforceability shall not affect any other provision of this
Agreement, the balance of which will remain in and have its intended full force and effect; provided, however that if such invalid
or unenforceable provision may be modified so as to be valid and enforceable as a matter of law, such provision shall be deemed to
have been modified so as to be valid and enforceable to the maximum extent permitted by law.

 

20. Complete
Agreement. This Agreement set forth the entire agreement between the Parties, and fully supersede any and all prior agreements
(including, but not limited to, any employment agreements, compensation agreements, Board agreements) or understandings, whether
oral or written, between the Parties pertaining to actual or potential claims arising from Executive’s employment with NYIAX.
Executive expressly warrants and represents that no promise or agreement which is not expressed in this Agreement has been made to
Executive in executing this Agreement.

 

    6

     

    

 

21. No Admission of
Liability. The execution of this Settlement Agreement shall not be construed as an admission of any liability whatsoever by
either Party, which liability is expressly disclaimed by each of them.

 

22.
Waiver. A waiver by NYIAX of a breach of any provision of this Agreement by Executive shall not operate or be construed
as a waiver or estoppel of any subsequent breach by Executive. No waiver shall be valid unless in writing and signed by an authorized
officer of NYIAX.

 

23.
Amendment. This Agreement may not be altered, amended, or modified except in writing signed by the Parties.

 

24.
Joint Participation. The Parties hereto participated jointly in the negotiation and preparation of this Agreement. Accordingly,
it is agreed that no rule of construction shall apply against any Party or in favor of any Party. This Agreement shall be construed as
if the Parties jointly prepared this Agreement, and any uncertainty or ambiguity shall not be interpreted against one Party and in favor
of the other.

 

25.
Knowing and Voluntary. Executive acknowledges that she is knowingly and voluntarily waiving and releasing any rights she
may have under the federal Age Discrimination in Employment Act (the “ADEA Waiver”) and that the consideration given for the
ADEA Waiver is in addition to anything of value to which she is already entitled. She further acknowledges that: (a) ADEA Waiver
does not apply to any claims that may arise after she signs this Agreement; (b) she should consult with an attorney prior to executing
this Agreement; (c) she has 21 calendar days within which to consider this Agreement (although she may choose to execute Agreement earlier);
(d) she has 7 calendar days following the execution of the Agreement to revoke this Agreement; and (e) the Agreement will not be effective
until the eighth day after she signs this Agreement provided that she has not revoked it (the “Effective Date”). She agrees
that any modifications, material or otherwise, made to this Agreement does not restart or affect in any manner the original 21-day consideration
period provided in this Paragraph. To revoke the Agreement, Executive must email Tom O’Neill, NYIAX Chairman, at toneill1001@gmail.com
prior to the end of the 7 -day period. Executive acknowledges that her consent to this Agreement is knowing and voluntary.

 

25.
Governing Law. This Agreement is made under and shall be governed by and construed in accordance with the laws of the State
of New York, without giving effect to its choice of law provisions.

 

26. Execution of
Agreement. This Agreement may be executed in counterparts, each of which shall be considered an original, but which when taken
together, shall constitute one Agreement. The Agreement, to the extent signed and delivered by means of a facsimile machine or by
PDF File (portable document format file), shall be treated in all manner and respects as an original agreement or instrument and
shall be considered to have the same binding legal effect as if it were the originally signed version delivered in person. At the
request of any Party hereto, each other Party shall re-execute original forms hereof and deliver them to all other Parties.

 

PLEASE READ THIS ENTIRE AGREEMENT
AND CAREFULLY CONSIDER ALL OF ITS PROVISIONS BEFORE SIGNING IT. TO THE EXTENT PROVIDED BY LAW, THIS AGREEMENT CONTAINS A RELEASE OF ALL
KNOWN AND UNKNOWN CLAIMS, INCLUDING ALL CLAIMS UNDER FEDERAL, STATE, AND LOCAL LAWS.

 

[THE REMAINDER OF THIS PAGE
IS LEFT INTENTIALLY BLANK] 

 

    7

     

    

 

	Carolina
    Abenante	 
	 	 
	/s/
    Carolina Abenante	 
	Carolina
    Abenante	 
	Date:
    May 23, 2022	 

 

	NYIAX	 
	 	 	 
	By:	/s/ Tom O’Neill	 
	Title: 	Chairman	 
	Date:	May 23, 2022	 

 

 

8

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00345-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00345-of-00352.parquet"}]]